Note: Ingredients listed on restricted chemical lists
EC/CAS
203-404-7/106-50-3
Name of the chemical
p-Phenylenediamine
Concentration
1-<5%
EC/CAS
210-431-8/615-50-9
Name of the chemical
1,4-Benzenediamine, 2-methyl- 2,5-Diaminotoluene sulphate
Concentration
1-<5%
EC/CAS
215-647-6/1336-21-6
Name of the chemical
ammonium hydroxide
Concentration
<1%
EC/CAS
205-507-2/141-86-6
Name of the chemical
Pyridine-2,6-diyldiamine
Concentration
<1%
General Information
Revision date
2017-04-08
Product name
INTENSIVE Augenbrauen- und Wimpernfarbe SCHWARZ
Emergency telephone
+49 (0) 170 2450126
Icons in SDS
Company Information
company name
Biosmetics GmbH
e-mail address of the competent person responsible for the Safety Data Sheet
info@tge-consult.de
GHS Information
Signal word
Warning
Hazard Codes
Hazard statements (CLP)
H317, H412
Hazard statements
Code
Statements
H317
May cause an allergic skin reaction
Section 2
2.1 Classification of the substance or mixture
Regulation (EC) No. 1272/2008
Hazard categories
Respiratory or skin sensitisation: Skin Sens. 1 Hazardous to the aquatic environment: Aquatic Chronic 3
Hazard statements
May cause an allergic skin reaction. Harmful to aquatic life with long lasting effects. H317 May cause an allergic skin reaction. H412 Harmful to aquatic life with long lasting effects.
2.2 Label elements
Regulation (EC) No. 1272/2008
Hazardous Ingredients
p-phenylenediamine 2-methyl-p-phenylenediamine sulphate
Signal word
Warning
Precautionary statements
P261 Avoid breathing vapour./Aerosol. P273 Avoid release to the environment. P280 Wear protective gloves/protective clothing/eye protection/face protection. P333+P313 If skin irritation or rash occurs: Get medical advice/attention. P362+P364 Take off contaminated clothing and wash it before reuse. P501 Dispose of contents/container to in accordance with official regulations.
Supplemental label elements
Labelling according to cosmetic directive.
2.3 Other hazards
The substances in the mixture do not meet the PBT/vPvB criteria according to REACH, annex XIII.